ArticleExperimental and therapeutic medicine2023

Efficacy and safety of vedolizumab in the treatment of patients with inflammatory bowel disease: A systematic review and meta‑analysis of randomized controlled trials.

Hui-Jun Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.